[Hoboken, New Jersey]. In a significant boost for the local innovation ecosystem, Bullseye Biodevices, Inc. has been awarded $25k in funding through the SBIR/STTR Direct Financial Assistance Program by the New Jersey Economic Development Authority (NJEDA) and the Commission on Science, Innovation and Technology (CSIT). This grant is designed to bridge the gap between initial research and commercial viability for the state’s most promising high-tech enterprises.

The award serves as a strategic endorsement of Bullseye Biodevices' current trajectory and provides the capital needed to accelerate the development of a biosensing tumor-detection device. By leveraging this state-level support alongside federal SBIR/STTR initiatives, the company aims to expedite its prototyping phase and strengthen its competitive edge in the global marketplace.